Medicamen Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 19	Mar ' 18

Profit before tax

15.00

14.91

12.49

12.03

10.11

Net cashflow-operating activity

-3.50

4.81

13.29

4.30

-5.45

Net cash used in investing activity

-7.54

-8.47

-18.12

-14.76

-7.99

Netcash used in fin. activity

27.67

4.39

5.68

-3.69

33.14

Net inc/dec in cash and equivlnt

16.63

0.73

0.85

-14.15

19.70

Cash and equivalnt begin of year

3.81

3.08

2.23

22.66

2.97

Cash and equivalnt end of year

20.44

3.81

3.08

8.52

22.66